Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Abuja Heart Study: Prospective Epidemiologic Investigation of Cardiovascular Diseases (AHS)
This study is not yet open for participant recruitment.
Verified by Healthsystem Plus, July 2008
Sponsors and Collaborators: Healthsystem Plus
Federal Ministry Of Health Nigeria
University of Bergen
Information provided by: Healthsystem Plus
ClinicalTrials.gov Identifier: NCT00629954
  Purpose

This is a multi-site prospective epidemiologic investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.


Condition
Cardiovascular Diseases
High Blood Pressure

MedlinePlus related topics: High Blood Pressure
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Abuja Heart Study (AHS) is a Multi-Site Prospective Epidemiologic Investigation of Cardiovascular Disease (CVD) .

Further study details as provided by Healthsystem Plus:

Primary Outcome Measures:
  • determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors [ Time Frame: 5 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • familial or hereditary factors [ Time Frame: 10 ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 3000
Study Start Date: October 2008
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
I

Detailed Description:

WHO predicted statistics indicate that come 2030 the world will experience a shift in death distribution from communicable to non communicable diseases.CVD will become the number one cause of death in developing countries however, relatively few population-based studies have examined CVD in Nigeria .

Although control of communicable , childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate informations.

Prior to the commencement of the study, series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight, blood pressure, electrocardiogram and laboratory measurements for cholesterol, other lipids, glucose , among others.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Abuja residents from the rural and metropolitan area.

Criteria

Inclusion Criteria:

  • No known history of cardiovascular disease

Exclusion Criteria:

  • Heart disease
  • Stroke
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00629954

Contacts
Contact: Uchenna N Onyeachom uche_onyeachom@healthsystemplus.org

Locations
Nigeria, Federal Capital Territory
Federal Ministry Health
Abuja, Federal Capital Territory, Nigeria
Sponsors and Collaborators
Healthsystem Plus
Federal Ministry Of Health Nigeria
University of Bergen
Investigators
Principal Investigator: Uchenna N Onyeachom Healthsystem Plus
Principal Investigator: Ngozi A Njepuome Department Of Public Health, Federal Ministry Of Health Nigeria
  More Information

Responsible Party: Healthsystem Plus ( Heallthsystem Plus )
Study ID Numbers: HIFA-001
Study First Received: February 25, 2008
Last Updated: July 8, 2008
ClinicalTrials.gov Identifier: NCT00629954  
Health Authority: Nigeria: The National Agency for Food and Drug Administration and Control

Keywords provided by Healthsystem Plus:
ABUJA HEART STUDY NIGERIA
CARDIOVASCULAR DISEASES

Study placed in the following topic categories:
Vascular Diseases
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009